Skip to content

Article

Primary: BradyPLUS Launches $2.8B First Lien Term Loan B Due 2032 to Refinance Existing $2.527B Privately-Placed Term Loan, Refinance ABL Draws Relating to Imperial Dade Merger

For covenant analysis of this transaction, please submit the loan documents to [email protected].

 

Company: BradyPLUS (the “Company”)
Borrower: BradyPLUS Holdings, LLC (the “Borrower”)
Business: BradyPLUS is a leading distributor and solutions provider focused on JanSan, foodservice, and industrial packaging products
Corporate Ratings (M/S): To be announced
Facility Ratings (M/S): To be announced
UoP: Refinance existing $2,527MM Privately-Placed Term Loan, refinance ABL draws, fund transaction related fees and expenses and cash to balance sheet
Facility: $2,800MM First Lien Term Loan B
Maturity: December 2032, subject to springing maturity to the earlier of December 11, 2030 or 180 days before Imperial Dade 2L maturity, if certain Imperial Dade loans are not repaid, extended, or refinanced; springing maturity applies post-BradyPLUS/Imperial Dade merger
Merger Mechanics: Upon consummation of the previously announced merger with Imperial Dade, lenders to BradyPLUS will cashlessly exchange or otherwise be moved under the Imperial Dade credit group on a fully pari passu basis
Pricing: S+325-350 / 0.00% Floor @ 99.50
Call Protection: 101 soft call for 6 months
Admin Agent: J.P. Morgan
Lead Left Arranger and Bookrunner: J.P. Morgan
Other Lead Arrangers and Bookrunners: BofA, BMO, GS, Jefferies, UBS, WFS, Santander, Citizens, Mizuho, MUFG, TDS and US Bank
Timing: Lender Call: Monday 12/1 @ 1:00PM ET
Commitment Deadline: Thursday 12/11 @ 12:00PM ET

Octus reported on Sept. 16 that JPMorgan was preparing to launch a $2.9 billion leveraged loan financing food packaging supplier Imperial Dade’s merger with BradyPlus.

This publication has been prepared by Octus, Inc. or one of its affiliates (collectively, "Octus") and is being provided to the recipient in connection with a subscription to one or more Octus products. Recipient’s use of the Octus platform is subject to Octus Terms of Use or the user agreement pursuant to which the recipient has access to the platform (the “Applicable Terms”). The recipient of this publication may not redistribute or republish any portion of the information contained herein other than with Octus express written consent or in accordance with the Applicable Terms. The information in this publication is for general informational purposes only and should not be construed as legal, investment, accounting or other professional advice on any subject matter or as a substitute for such advice. The recipient of this publication must comply with all applicable laws, including laws regarding the purchase and sale of securities. Octus obtains information from a wide variety of sources, which it believes to be reliable, but Octus does not make any representation, warranty, or certification as to the materiality or public availability of the information in this publication or that such information is accurate, complete, comprehensive or fit for a particular purpose. Recipients must make their own decisions about investment strategies or securities mentioned in this publication. Octus and its officers, directors, partners and employees expressly disclaim all liability relating to or arising from actions taken or not taken based on any or all of the information contained in this publication. © 2025 Octus. All rights reserved. Octus(TM) and the Octus logo are trademarks of Octus Intelligence, Inc.